Post
newsbot
SOLARA
Solara Active Pharma Sciences incorporates wholly-owned subsidiary
News Summary
• Solara Active Pharma Sciences has established a wholly-owned subsidiary named 'Synthix Global Pharma Solutions' as of April 29, 2025.
• This subsidiary is part of the company's strategy to demerge its CRAMS and polymers business into a separate entity.
• Solara is recognized as a dynamic and customer-focused manufacturer of Active Pharmaceutical Ingredients (APIs).
Apr 30 11:21 PM